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There is considerable interest in the central actions of insulin and leptin. Both induce
sympatho-excitation. This study (i) investigated whether centrally administered leptin and
insulin together elicits greater increases in renal sympathetic nerve activity (RSNA), mean
arterial pressure (MAP) and heart rate (HR) than when given alone, and (ii) quantified
the number of activated neurons in brain regions influencing SNA, to identify potential
central sites of interaction. In anesthetised (urethane 1.4–1.6 g/kg iv) male Sprague-
Dawley rats, RSNA, MAP, and HR were recorded following intracerebroventricular (ICV)
saline (control; n = 5), leptin (7 µg; n = 5), insulin (500 mU; n = 4) and the combination
of leptin and insulin; (n = 4). Following leptin or insulin alone, RSNA was significantly
increased (74 and 62% respectively). MAP responses were not significantly different
between the groups. Insulin alone significantly increased HR. Leptin alone also increased
HR but it was significantly less than following insulin alone (P < 0.005). When leptin
and insulin were combined, the RSNA increase (124%) was significantly greater than
the response to either alone. There were no differences between the groups in MAP
responses, however, the increase in HR induced by insulin was attenuated by leptin. Of
the brain regions examined, only in the arcuate nucleus did leptin and insulin together
increase the number of Fos-positive cell nuclei significantly more than leptin or insulin
alone. In the lamina terminalis and rostroventrolateral medulla, leptin and insulin together
increased Fos, but the effect was not greater than leptin alone. The results suggest that
when central leptin and insulin levels are elevated, the sympatho-excitatory response
in RSNA will be greater. The arcuate nucleus may be a common site of cardiovascular
integration.
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INTRODUCTION
Insulin is produced by the pancreas and released into the circulation in response to elevated glucose.
In addition to insulin’s critical role in glucose homeostasis, there is now considerable interest in
its role in regulating the autonomic nervous system. Insulin can induce increases in sympathetic
outflow to cardiovascular organs, such as the kidney and skeletal muscle vasculature, by activating
receptors within the central nervous system (Morgan et al., 2008; Morgan and Rahmouni, 2010).
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Leptin is released from adipocytes and it acts centrally to
influencemetabolic and cardiovascular functions (Elmquist et al.,
1997; Mark et al., 1999, 2002; Rahmouni et al., 2005). It acts
within the brain to increase sympathetic nerve activity to the
kidney (Dunbar et al., 1997; Rahmouni and Haynes, 2004;
Rahmouni et al., 2004). The sympatho-excitatory actions of leptin
to the kidney makes an important contribution to the abnormally
elevated RSNA observed in obesity or overweight conditions
(Haynes et al., 1997; Prior et al., 2010).
Both leptin and insulin can be transported across the blood
brain barrier to activate brain nuclei involved in cardiovascular
and metabolic regulation. Pathways involving the activation of
melanocortin 4 receptors (MC4) is a key common mechanism
mediating the increases in renal sympathetic nerve activity
(RSNA) induced by leptin and insulin (Rahmouni et al., 2003),
suggesting the potential for an interaction on RSNA, such that
increased levels of both hormones could result in an additive
action on RSNA. Interestingly both insulin and leptin can
regulate each other’s production and release, such that an increase
in plasma levels of insulin can lead to an increase in leptin levels
and vice versa (Santos et al., 2000; Borer, 2014), which further
suggests potential interactions of the two hormones. Thus, in
order to explore the possibility that insulin and leptin interact
within the brain to induce greater increases in RSNA, the first
aim of the present study was to compare RSNA in response to
administration of leptin and insulin alone and in combination.
The second aim was to explore potential sites where leptin
and insulin may interact. Thus, we also quantified the number
of activated neurons in brain regions, known to influence the
sympathetic nervous system, and compared their distribution
after central administration of leptin and insulin alone and both
combined.
MATERIALS AND METHODS
Animals
Experiments were performed to comply with the Prevention
of Cruelty to Animals Act 1986 (Australia). All experimental
protocols conform with the “Guiding Principles for Research
Involving Animals and Human Beings” and the guidelines set
out by the “Australian Code of Practice for the Care and Use
of Animals for Scientific Purposes,” 2013 (National Health and
Medical Research Council of Australia) and were approved by
the Royal Melbourne Institute of Technology (RMIT) University
Animal Ethics Committee. Male Sprague–Dawley rats were
obtained from the ARC Animal Resources Center (Western
Australia, Australia). Rats were housed under a 12:12 h light/dark
cycle at 23◦C and allowed free access to standard rat chow and
water.
Procedures
General
General anesthesia was induced using isoflurane in O2 (2.5–5%)
on the day of the experiment to allow catheterization of the
femoral vein and artery. The catheter was inserted into the
femoral vein, so that general anesthesia could be maintained
with intravenous urethane (1.4–1.6 g/kg initially, followed by
supplemental doses of 0.05 ml of a 25% solution if required).
The depth of anesthesia was maintained to ensure the absence
of corneal and pedal pinch reflexes. The femoral artery was
cannulated for arterial blood pressure monitoring. Mean arterial
pressure (MAP) and heart rate (HR) were calculated from
the arterial pressure pulse using LABCHART (ADInstruments,
Castle Hill, NSW, Australia). Rats were kept on a heating pad for
the duration of the experiments to maintain body temperature at
∼37.5◦C.
Renal Sympathetic Nerve Activity
A flank incision was made to expose the left kidney
retroperitoneally. Using an operating microscope, the renal
nerve was carefully dissected free of surrounding tissue. Under
mineral oil, the renal nerve was then cut and the proximal end
was placed onto the bared tips of two Teflon-coated silver wire
electrodes.
The RSNA was amplified using a low-noise differential
amplifier (models ENG 187B and 133, Baker Institute, Victoria,
Australia), filtered (band pass 100–1000 Hz), rectified, and
integrated at 0.5 s intervals. The signal was recorded using
a PowerLab data acquisition system (ADInstruments, NSW,
Australia).
Microinjections into the Lateral Brain Ventricle (ICV)
Animals were placed prone, and their heads were mounted in
a Stoelting stereotaxic frame, so that bregma and lambda were
positioned on the same horizontal plane. To expose the dorsal
surface of the brain, a hole (diameter 2 mm) centered 0.7 mm
caudal and 1.4 mm lateral from bregma, was drilled into the
skull. After the drilling procedure, the hole was covered with
cotton wool soaked in normal saline to prevent drying of the
exposed surface. A microinjection was made unilaterally using a
fine glass micropipette (tip diameter 50–70 µm) inserted into the
lateral brain ventricle (stereotaxic coordinates: 0.7 mm caudal to
bregma, 1.4 mm lateral to midline, and 3.7–3.9 mm ventral to the
surface of the dura). After the microinjection, the micropipette
was left in place for 1 min. At the end of the experiment, a small
amount of pontamine sky blue was microinjected using the same
coordinates to confirm microinjection into the lateral ventricle.
Experimental Protocols
MAP, HR and RSNA were measured prior to
intracebroventricular (ICV) injection of vehicle (saline 5
µl; n = 5), leptin (7 µg in 5 µl; n = 5) or insulin (500 mU
in 5 µl; n = 4) alone or in combination [leptin (7 µg in 5
µl) was administered 15 min after insulin (500 mU in 5 µl)
(n = 4)], and the responses were monitored for 3 h after the last
injection. Apart from instances in which leptin and insulin were
administered in the one animal, only one injection per rat was
performed. The doses of each hormone were chosen on the basis
of previous studies (Rahmouni et al., 2009; Kosari et al., 2011).
The doses used are larger than those observed in plasma as noted
previously (Azuma et al., 2003; Degawa-Yamauchi et al., 2003;
Tovar et al., 2005; Kosari et al., 2012). The difference in amounts
is likely to be related to the concentration required at the actual
site of action.
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Immunohistochemistry
At the end of the experiment, the animals were perfused with
200 ml of 0.1 M phosphate buffered saline (PBS, pH 7.2)
transcardially, followed with 200 ml of 4% para-formaldehyde in
0.1 M PBS. The brains were removed carefully and post-fixed for
3–3.5 h and then transferred to a solution of 20% sucrose in PBS
0.1 M and stored at 4◦C.
Brains were sliced into a series of coronal sections (40 µm
thick) using a cryostat (Leica, CM1900). Sections were collected
and left in cryoprotectant until processed. One in five sections
were then collected and processed immunohistochemically as
free floating sections for the detection of Fos protein. In brief,
the process involved placing the sections in 0.5% H2O2 for
15min to destroy endogenous peroxidase activity. This was
followed by incubation in 10% normal horse serum (NHS) and
0.5% Triton X-100 for 60 min to facilitate antibody penetration.
Sections were then incubated in the primary antibody raised
in rabbit against Fos (1:5000, rabbit polyclonal IgG, c-Fos (K-
25): sc-253, Santa Cruz Biotechnology, CA, USA;) overnight
at 4◦C. Sections were then incubated with biotinylated anti
rabbit secondary antibody raised in horse (1:400, Sigma Aldrich,
Australia) for 90 min. This was followed by Extravidin–
peroxidase complex (1:400, Sigma Aldrich, Australia) for 45
min. Sections were washed three times in 0.1 M PBS (5
min each time) between each incubation. Sections were then
placed for 10 min in 0.01% 3,3′-diaminobenzidine hydrochloride
(DAB; sigma Aldrich, Australia) + 0.02% Nickel ammonium +
0.02% Cobalt chloride in PBS. 5 µl of 30% hydrogen peroxide
was added to begin the reaction. To end the reaction the
sections were washed with PBS and then they were placed onto
gelatine-coated slides and left overnight to dry, followed by
coverslipping with Depex (Sigma Aldrich Australia) the next
day.
Statistical Analysis
Physiological Parameters
The resting levels of MAP and HR, and RSNA before each
injection were averaged from three 5 min recordings taken 15–30
min prior to the first injection. The average levels were compared
between groups using one-way ANOVA. The integrated RSNA,
averaged over 1–2 min, was calculated at 15 min intervals
over the period of 180 min, and expressed as a percentage of
the resting level before the drug injections. Changes in MAP,
heart rate, and RSNA were compared between groups in each
experimental series by using two-way ANOVA. All results are
expressed as the mean± SE. P < 0.05 was considered statistically
significant.
Immunohistochemistry
Under a bright field illumination, Fos-positive cell nuclei were
visualized and counted unilaterally, except in midline structures
[organum vasculosum of the lamina terminalis (OVLT), medium
preoptic nucleus and raphe pallidus] at 200 × magnification.
At least two sections per brain nucleus were examined in each
animal. The average number of Fos-positive cell nuclei per
section was calculated for each brain region in each animal and
comparisons between the groups were performed using one-way
ANOVA.
For both the physiological and immunohistochemical data,
following the detection of an overall significant difference
between groups, comparisons between groups administered the
hormones and control, and between leptin + insulin combined
vs. leptin or insulin alone, were made using Holm-Sidak’s
multiple comparison test. All results are expressed as means ±
SE. P < 0.05 was considered to be statistically significant.
PRISM software was used.
RESULTS
Effects of ICV Injection of Leptin and
Insulin on RSNA
Following ICV injection of leptin alone RSNA increased
significantly by 74 ± 17% (P < 0.0001 compared to saline;
Figure 1). When insulin was administered alone the increase
in RSNA was similar to that of leptin reaching a maximum
of 62 ± 13% (P < 0.0001 compared to saline; Figure 1).
Following the ICV administration of the combination of
leptin and insulin the increase in RSNA was much greater
reaching a maximum response of 124 ± 40% by 120 min
(P < 0.0001 compared to control). The marked increase
in RSNA was significantly greater than that observed
after each hormone was administered alone (P < 0.0005;
Figure 1).
Effects of ICV Injection of Leptin and
Insulin on Map and HR
Compared to saline, there were no marked changes in MAP
during the 3 h observation period following leptin and insulin
administered alone or combined (Figure 2). However, HR
increased significantly following insulin alone compared to saline
(P < 0.0001) (Figure 2). Leptin alone also significantly increased
FIGURE 1 | Percent changes in renal sympathetic nerve activity (RSNA)
from baseline levels over time after intracerebroventricular injection of
leptin (n = 5) (7 µg/5 µl), insulin (n = 4) (500 mU/5 µl), saline (n = 5) (5
µl) and the combination of leptin and insulin (n = 4). *P < 0.0001 leptin
alone, insulin alone and both combined compared to saline; #P < 0.001
insulin alone compared to leptin and insulin combined or leptin alone.
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FIGURE 2 | Changes in mean arterial pressure (MAP) and heart rate (HR) over time induced by the intracerebroventricular administration of leptin (n =
5) (7 µg/5 µl), insulin (n = 4) (500 mU/5 µl), saline (n = 5) (5 µl) and the combination of leptin and insulin (n = 4). *P < 0.0001 Leptin alone, insulin alone and
both combined compared to saline; #P < 0.0005 leptin and insulin combined compared to insulin alone.
HR compared to saline (Figure 2). When insulin and leptin
were combined, the HR response was significantly greater than
saline (P < 0.0001), but significantly less than that of insulin
alone (P < 0.001) (Figure 2). The response was similar to that
of leptin alone. Thus, the presence of leptin attenuated insulin’s
tachycardic actions (Figure 2).
Resting MAP and HR prior to the ICV injections are shown
in Table 1. No significant differences were detected between the
groups (Table 1).
Effects of Leptin and Insulin on
Fos-positive Cell Nuclei
Lamina Terminalis
The numbers of Fos-positive cell nuclei in the OVLT following
ICV injection of insulin alone were not significantly different
compared to saline (control) (Figure 3). However, in this
brain region, leptin alone significantly increased the number
of Fos-positive cell nuclei compared to control (100 ± 6
vs. 45 ± 7/section, P < 0.01) (Figure 3). When leptin and
insulin were combined the number of Fos-positive cell nuclei
observed almost doubled (91 ± 8) compared to control and was
significantly greater than that observed following insulin alone (P
< 0.05) (Figure 3). The response following combined leptin and
insulin was similar in magnitude to that following leptin alone
(Figure 3). Thus, insulin did not influence the response to leptin
in the OVLT.
In the median preoptic (MnPO) nucleus, similar effects were
observed; insulin alone did not significantly affect the number of
Fos-positive cell nuclei compared to the saline control (Figure 3)
but there was a significant increase in Fos production after
ICV leptin alone (Figure 3). The administration of leptin and
insulin in combination also significantly increased the number
of Fos-positive cell nuclei compared to control (P < 0.01)
(Figure 3). This increase in Fos production was similar to that
observed after leptin alone (Figure 3). However, the response
to the combination of insulin and leptin was significantly
greater that that observed following insulin alone (P < 0.05)
(Figure 3).
TABLE 1 | Resting mean arterial pressure (MAP) and heart rate (HR) prior
to intracerebroventricular injection of saline (n = 5), leptin (7 µg, n = 5),
insulin (500 mU, n = 4) and the combination of leptin and insulin (n = 4) in
anesthetised rats.
Saline Leptin Insulin Leptin + Insulin
MAP (mmHg) 93.5 ± 4.1 79.7 ± 1.6 88.0 ± 6.8 86.2 ± 5.6
HR (beats/min) 360 ± 7 336 ± 11 312 ± 19 318 ± 28
Hypothalamus
Arcuate nucleus
In the arcuate nucleus (ARC), leptin alone and insulin alone
significantly increased the number of Fos-positive cell nuclei
compared to control (P < 0.05) (Figure 4). The combined
administration of leptin and insulin produced a significantly
greater increase in the number of Fos-positive cell nuclei
in the ARC compared with either hormone alone (P <
0.05) (Figures 4, 5). Thus, the response to the combined
administration of insulin and leptin was enhanced compared to
the responses of the individual hormones.
Paraventricular and supraoptic nuclei
In the hypothalamic paraventricular nucleus ICV administration
of leptin alone induced a significant increase in the number of
Fos-positive cell nuclei compared to control (Figure 4). However,
insulin alone or the combination of leptin and insulin did
not attain statistically significant increases compared to control
(Figure 4).
In the supraoptic nucleus, although a significant difference
between the treatment groups was detected overall (P< 0.05), the
analysis of the individual comparisons between a treated group
(i.e., leptin, insulin alone, or combined) compared to control did
not identify a statistically significant difference (Figure 4).
Medulla Oblongata
Fos-positive cell nuclei were examined in the nucleus tractus
solitarius (NTS), raphe pallidus (RPA), and rostral ventrolateral
medulla (RVLM) in the medulla oblongata. In the NTS and in the
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FIGURE 3 | Average number of Fos-positive cell nuclei per section in
the organum vasculosum of lamina terminalis (OVLT) and median
preoptic nucleus (MnPO) from rats administered
intracerebroventricular saline (control) (n = 5) (5 µl), leptin (n = 5) (7
µg/5 µl), insulin (n = 4) (500 mU/5 µl), and the combination of leptin
and insulin (n = 4). *P < 0.01 compared to saline; #P < 0.05 compared to
insulin alone.
RPA there were no significant differences between groups overall.
However, in the RVLM there was a significant difference between
the groups (P < 0.05). There was a significant increase in the
number of Fos-positive cell nuclei following the administration
of leptin alone (P < 0.05) but not with insulin alone (Figure 6).
Following the combination of leptin and insulin the increase in
Fos-positive cell nuclei was similar to that of leptin and two-
fold greater than in control (P < 0.05 compared to control)
(Figure 6). Thus, insulin did not affect the increase induced by
leptin in the RVLM.
DISCUSSION
This report is the first to demonstrate that the ICV administration
of leptin combined with insulin results in significantly greater
increases in RSNA compared with either hormone administered
alone. The sympatho-excitatory effect did not appear to be
a generalized response since the combined administration of
leptin and insulin did not result in an increased HR response,
rather the tachycardic effects elicited by insulin alone were
attenuated by the presence of leptin. We also investigated brain
FIGURE 4 | The average number of Fos-positive cell nuclei per section
in the arcuate (ARC), paraventricular (PVN) and supraoptic (SON)
nuclei after intracerebroventricular injection saline (control) (n = 5) (5
µl), leptin (n = 5) (7 µg/5 µl), insulin (n = 4) (500 mU/5 µl), and the
combination of leptin and insulin (n = 4). *P < 0.01 compared to saline;
#P < 0.05 compared to insulin alone.
nuclei involved in autonomic regulation to determine whether
there was a correlation with those responses and increased
neuronal activation (detected by the presence of Fos-positive
cell nuclei) when leptin and insulin were administered. In the
regions we investigated, we found that in the ARC, OVLT,
MnPO, and RVLM the number of Fos-positive cell nuclei were
significantly greater following ICV injection of leptin and insulin
together compared to control. However, only in the ARC was the
increase significantly greater than insulin or leptin administered
alone.
Frontiers in Physiology | www.frontiersin.org 5 January 2017 | Volume 7 | Article 672
Habeeballah et al. Insulin and Leptin and Sympathetic Nerve Activity
FIGURE 5 | Photomicrographs showing Fos-positive cell nuclei in the arcuate nucleus of rats following centrally administered saline (5 µl; control),
leptin (7 µg), insulin (500 mU) and leptin combined with insulin. Bar = 100 µm. Dashed lines outline the arcuate nucleus. The third ventricle is to the right of
each photomicrograph.
The present work is the first to show a greater sympatho-
excitatory response when leptin and insulin are present together
compared to the responses elicited by each alone. The present
work confirms previous studies that have shown significant
increases in RSNA following the central administration of leptin
alone or insulin alone (Dunbar et al., 1997; Rahmouni and
Haynes, 2004; Morgan et al., 2008; Morgan and Rahmouni,
2010). The significance of our current work is that it highlights
the potential for a much greater sympatho-excitatory effect on
RSNA in conditions in which leptin and insulin are elevated,
such as metabolic syndrome and obesity (Haynes et al., 1997
p. 2983; Paracchini et al., 2005; Schwartz and Porte, 2005;
Prior et al., 2010). In those conditions, RSNA is abnormally
elevated and leptin is believed to make a critical contribution
to the increase (Simonds et al., 2014). Our findings suggest that
the considerable contribution of leptin to this elevated RSNA
may be, in part, due to the presence of increased levels of
insulin.
In the present study we found that central administration of
insulin increased heart rate, however, the response was prevented
when leptin was present. Since the changes in heart rate elicited
by central insulin are mediated by increases in sympathetic
nerve activity (Cabou et al., 2007), the inhibition of this effect
when leptin was present contrasts dramatically with the observed
effect on RSNA, and suggests that the central interactions
between leptin and insulin on the sympathetic nervous system
are complex and may reflect differences in the output to different
organs such that effects on the renal output is an additive
response whilst that to the heart is an antagonistic interaction.
There was no effect onMAP following the ICV administration
of leptin or insulin administered alone or in combination,
suggesting that increases in RSNA are not sufficient to acutely
increase MAP. The present findings are consistent with previous
reports that found that acute ICV administration of leptin did not
increase MAP over the time frame of our observations (Dunbar
et al., 1997; Rahmouni and Morgan, 2007). Similarly, central
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FIGURE 6 | Average number of Fos-positive cell nuclei per section in
the nucleus tractus solitarius (NTS), raphe pallidus (RPA) and rostral
ventrolateral medulla (RVLM), following saline (control) (n = 5) (5 µl),
leptin (n = 5) (7 µg/5 µl), insulin (n = 4) (500 mU/5 µl), and the
combination of leptin and insulin (n = 4). (*P < 0.05 compared to saline).
administration of insulin has also been reported to have little
effect acutely on blood pressure (Baron et al., 1993; Vollenweider
et al., 1993; Rahmouni and Haynes, 2004).
In contrast, effects on MAP following chronic systemic or
central administration, for 3–10 days, of leptin or insulin alone
have beenmore consistent reporting significantly increasedMAP
responses (Meehan et al., 1994; Shek et al., 1998; Dubinion et al.,
2011). Since renal function is an important determinant in the
regulation of chronic blood pressure, the possibility exists that if
the effect of the acute combination of leptin and insulin on RSNA
could be reproduced with chronic infusions, then increases in
MAP in conditions in which both hormones are chronically
elevated may occur, but this awaits further investigation.
Previous work on interactions between leptin and insulin has
focussed on metabolic functions, with little investigation into
interactions on cardiovascular function. In particular, there is a
distinct gap investigating an interaction on the cardiovascular
responses arising from leptin and insulin acting within the brain,
despite the fact that the central mechanisms that mediate the
increase in RSNA induced by leptin or insulin alone have a
common pathway that involves the activation of MC4 receptors
(Rahmouni et al., 2003). This strongly suggests that an interaction
is likely, and the present study now provides evidence to support
a central interaction on RSNA.
The central interaction of insulin and leptin may not be
restricted to the renal output. Evidence indicates that increases
in lumbar sympathetic nerve activity induced by centrally
administered insulin involves PI3K as is the case with leptin,
whilst the increase in sympathetic nerve activity to brown adipose
tissue induced by leptin or insulin involves activation of ERK1/2
(Rahmouni and Haynes, 2004). Thus, an interaction between
leptin and insulin influencing at least three sympathetic outputs
is a distinct possibility.
In the present study we investigated the distribution of
activated neurons using the protein marker, Fos, in cell nuclei
in brain regions known for their contribution to cardiovascular
regulation. Only in the ARCwas the number of activated neurons
significantly greater following the combination of leptin and
insulin than the increase seen after either hormone alone. This
result is in agreement with reports that show leptin and insulin
act within the ARC to increase sympathetic nerve activity (Elias
et al., 1999; Cowley et al., 2001; Rahmouni et al., 2003; Rahmouni
and Haynes, 2004; Rahmouni and Morgan, 2007; Morgan and
Rahmouni, 2010; Cassaglia et al., 2011; Harlan et al., 2011; Ha
et al., 2013). Thus, the activation of neurons in the ARC would be
in accord with the increase in RSNA induced by leptin or insulin.
The greater number of activated neurons in the ARC after the
administration of leptin and insulin in combination correlates
with the greater increase in RSNA compared to each hormone
alone that we observed.
We found a significant increase in Fos-positive cell nuclei
in the lamina terminalis (OVLT, MnPO), hypothalamic PVN
and in the RVLM following leptin administration. We did
not detect a statistically significant increase following insulin
in those same regions. Although, the PVN and RVLM are
believed to be involved in mediating the sympatho-excitatory
effects of hyperinsulinemia, microinjections of insulin directly
into those brain nuclei did not induce an increased sympathetic
nerve activity suggesting there is no direct activation of insulin
receptors in those brain nuclei (Bardgett et al., 2010; Ward
et al., 2011; Stocker and Gordon, 2015). Since we found that
insulin alone increased RSNA, it was perhaps, surprising that
we did not detect an increase in Fos in those regions. Whether
the type of anesthesia used (e.g., urethane in this study and
alpha chloralose in those mentioned above) contributes to this
anomaly is unknown. In contrast, no anomaly appears to exist
with leptin since it significantly increased Fos production in
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the PVN and RVLM. Other factors that could contribute to the
greater basal Fos may include duration of the stimulus and the
surgical intervention that has occurred. Additionally, it should
be noted that subtle influences or changes in the nuclei that affect
sympathetic outflowmay not be easily visualized by the use of the
immunohistochemical detection of Fos.
In theOVLT,MnPO, and RVLM the combined administration
of leptin and insulin significantly increased Fos-positive cell
nuclei but the effects were similar to leptin alone. Thus, in those
brain nuclei, the results suggest that the increase in Fos-positive
nuclei were due primarily to leptin and that that there was no
evidence of an additive interaction between leptin and insulin in
those brain nuclei. These findings contrast with the observations
we made in the ARC, suggesting that interactions between
leptin and insulin in the brain may occur in selective brain
nuclei.
SUMMARY AND CONCLUSIONS
In summary, following ICV administration of leptin and insulin
together there was a significantly greater increase in RSNA than
either hormone alone. Insulin alone increased HR significantly
but this was prevented by the presence of leptin. MAP was
not significantly different between groups. Of the brain regions
examined, only in the arcuate nucleus did the combination of
leptin and insulin together increase the number of Fos-positive
cell nuclei significantly more than the increases following leptin
or insulin alone. In contrast, in the lamina terminalis and rostral
ventrolateral medulla, leptin and insulin combined increased
Fos-positive cell nuclei to levels similar to leptin alone. The
results suggest that where leptin and insulin are elevated, there
may be greater increases in RSNA. This may contribute to
cardiovascular complications. The arcuate nucleus may be a
common site of cardiovascular integration for leptin and insulin.
AUTHOR CONTRIBUTIONS
The work was performed in the laboratory of EB. EB devised
study, analyzed the data, interpreted the data and wrote
manuscript. HH and NA, performed experiments, analyzed and
interpreted the data and contributed to writing the manuscript.
TJ and MS contributed to the manuscript and interpretation of
the data. All authors approved the final version of the manuscript
and agree to be accountable for all aspects of the work in ensuring
that questions related to the accuracy or integrity of any part of
the work are appropriately investigated and resolved. All persons
designated as authors qualify for authorship, and all those who
qualify for authorship are listed.
REFERENCES
Azuma, K., Katsukawa, F., Oguchi, S., Murata, M., Yamazaki, H., Shimada, A.,
et al. (2003). Correlation between serum resistin level and adiposity in obese
individuals. Obes. Res. 11, 997–1001. doi: 10.1038/oby.2003.137
Bardgett, M. E., McCarthy, J. J., and Stocker, S. D. (2010). Glutamatergic
receptor activation in the rostral ventrolateral medulla mediates the
sympathoexcitatory response to hyperinsulinemia. Hypertension 55, 284–290.
doi: 10.1161/HYPERTENSIONAHA.109.146605
Baron, A. D., Brechtel-hook, G., Johnson, A., and Hardin, D. (1993). Skeletal-
muscle blood-flow - a possible link between insulin resistance and blood-
pressure. Hypertension 21, 129–135. doi: 10.1161/01.HYP.21.2.129
Borer, K. T. (2014). Counterregulation of insulin by leptin as key component
of autonomic regulation of body weight. World J. Diabetes 5, 606–629.
doi: 10.4239/wjd.v5.i5.606
Cabou, C., Cani, P. D., Campistron, G., Knauf, C., Mathieu, C., Sartori, C.,
et al. (2007). Central insulin regulates heart rate and arterial blood flow:
an endothelial nitric oxide synthase-dependent mechanism altered during
diabetes. Diabetes 56, 2872–2877. doi: 10.2337/db07-0115
Cassaglia, P. A., Hermes, S. M., Aicher, S. A., and Brooks, V. L. (2011).
Insulin acts in the arcuate nucleus to increase lumbar sympathetic
nerve activity and baroreflex function in rats. J. Physiol. 589, 1643–1662.
doi: 10.1113/jphysiol.2011.205575
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath,
T. L., et al. (2001). Leptin activates anorexigenic POMC neurons through a
neural network in the arcuate nucleus. Nature 411, 480–484. doi: 10.1038/350
78085
Degawa-Yamauchi, M., Bovenkerk, J. E., Juliar, B. E., Watson, W., Kerr, K., Jones,
R., et al. (2003). Serum resistin (FIZZ3) protein is increased in obese humans.
J. Clin. Endocrinol. Metab. 88, 5452–5455. doi: 10.1210/jc.2002-021808
Dubinion, J. H., da Silva, A. A., and Hall, J. E. (2011). Chronic blood pressure
and appetite responses to central leptin infusion in rats fed a high fat diet. J.
Hypertens. 29, 758–762. doi: 10.1097/HJH.0b013e328344280b
Dunbar, J. C., Hu, Y., and Lu, H. (1997). Intracerebroventricular leptin inreases
lumbar and renal sympathetic nerve activity and blood pressure in normal rats.
Diabetes 46, 2040–2043. doi: 10.2337/diab.46.12.2040
Elias, C. F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R. S., Bjorbaek, C., et al. (1999).
Leptin differentially regulates NPY and POMC neurons projecting to the
lateral hypothalamic area. Neuron 23, 775–786. doi: 10.1016/S0896-6273(01)
80035-0
Elmquist, J. K., Ahima, R. S., Maratos-Flier, E., Flier, J. S., and Saper, C. B.
(1997). Leptin activates neurons in ventrobasal hypothalamus and brainstem.
Endocrinology 138, 839–842. doi: 10.1210/endo.138.2.5033
Ha, S., Baver, S., Huo, L., Gata, A., Hairston, J., Huntoon, N., et al. (2013). Somato-
dendritic localization and signaling by leptin receptors in hypothalamic POMC
and AgRP neurons. PLoS ONE 8:e77622. doi: 10.1371/journal.pone.0077622
Harlan, S. M., Morgan, D. A., Agassandian, K., Guo, D. F., Cassell, M. D., Sigmund,
C. D., et al. (2011). Ablation of the leptin receptor in the hypothalamic
arcuate nucleus abrogates leptin-induced sympathetic activation. Circ. Res. 108,
808–812. doi: 10.1161/CIRCRESAHA.111.240226
Haynes, W. G., Sivitz, W. I., Morgan, D. A., Walsh, S. A., and Mark, A. L. (1997).
Sympathetic and cardiorenal actions of leptin. Hypertension 30, 619–623.
doi: 10.1161/01.HYP.30.3.619
Kosari, S., Rathner, J. A., and Badoer, E. (2012). Central resistin enhances renal
sympathetic nerve activity via phosphatidylinositol 3-kinase but reduces the
activity to brown adipose tissue via extracellular signal-regulated kinase 1/2.
J. Neuroendocrinol. 24, 1432–1439. doi: 10.1111/j.1365-2826.2012.02352.x
Kosari, S., Rathner, J. A., Chen, F., Kosari, S., and Badoer, E. (2011). Centrally
administered resistin enhances sympathetic nerve activity to the hindlimb but
attenuates the activity to brown adipose tissue. Endocrinology 152, 2626–2633.
doi: 10.1210/en.2010-1492
Mark, A. L., Correia, M. L., Rahmouni, K., and Haynes, W. G. (2002).
Selective leptin resistance: a new concept in leptin physiology
with cardiovascular implications. J. Hypertens. 20, 1245–1250.
doi: 10.1097/00004872-200207000-00001
Mark, A. L., Shaffer, R. A., Correia, M. L., Morgan, D. A., Sigmund, C. D., and
Haynes, W. G. (1999). Contrasting blood pressure effects of obesity in leptin-
deficient ob/obmice and agouti yellow obese mice. J. Hypertens. 17, 1949–1953.
doi: 10.1097/00004872-199917121-00026
Meehan, W. P., Buchanan, T. A., and Hsueh, W. (1994). Chronic insulin
administration elevates blood pressure in rats. Hypertension 23, 1012–1017.
doi: 10.1161/01.HYP.23.6.1012
Frontiers in Physiology | www.frontiersin.org 8 January 2017 | Volume 7 | Article 672
Habeeballah et al. Insulin and Leptin and Sympathetic Nerve Activity
Morgan, D. A., and Rahmouni, K. (2010). Differential effects of insulin on
sympathetic nerve activity in agouti obese mice. J. Hypertens. 28, 1913–1919.
doi: 10.1097/HJH.0b013e32833c2289
Morgan, D. A., Thedens, D. R., Weiss, R., and Rahmouni, K. (2008).
Mechanisms mediating renal sympathetic activation to leptin in
obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1730–R1736.
doi: 10.1152/ajpregu.90324.2008
Paracchini, V., Pedotti, P., and Taioli, E. (2005). Genetics of leptin and obesity: a
HuGE review. Am. J. Epidemiol. 162, 101–114. doi: 10.1093/aje/kwi174
Prior, L. J., Eikelis, N., Armitage, J. A., Davern, P. J., Burke, S. L., Montani, J. P.,
et al. (2010). Exposure to a high-fat diet alters leptin sensitivity and elevates
renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension
55, 862–868. doi: 10.1161/HYPERTENSIONAHA.109.141119
Rahmouni, K., and Haynes, W. G. (2004). Leptin and the cardiovascular system.
Recent Prog. Horm. Res. 59, 225–244. doi: 10.1210/rp.59.1.225
Rahmouni, K., Haynes, W. G., Morgan, D. A., and Mark, A. L. (2003). Role of
melanocortin-4 receptors in mediating renal sympathoactivation to leptin and
insulin. J. Neurosci. 23, 5998–6004. Available online at: http://www.jneurosci.
org/content/23/14/5998.long
Rahmouni, K., and Morgan, D. A. (2007). Hypothalamic arcuate nucleus mediates
the sympathetic and arterial pressure responses to leptin. Hypertension 49,
647–652. doi: 10.1161/01.HYP.0000254827.59792.b2
Rahmouni, K., Morgan, D. A., Morgan, G. M., Liu, X., Sigmund, C. D., Mark,
A. L., et al. (2004). Hypothalamic PI3K and MAPK differentially mediate
regional sympathetic activation to insulin. J. Clin. Invest. 114, 652–658.
doi: 10.1172/JCI21737
Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L., and Haynes, W. G.
(2005). Role of selective leptin resistance in diet-induced obesity hypertension.
Diabetes 54, 2012–2018. doi: 10.2337/diabetes.54.7.2012
Rahmouni, K., Sigmund, C. D., Haynes, W. G., and Mark, A. L. (2009).
Hypothalamic ERK mediates the anorectic and thermogenic sympathetic
effects of leptin. Diabetes 58, 536–542. doi: 10.2337/db08-0822
Santos, J. L., Pé rez-Bravo, F., Albala, C., Calvillán, M., and Carrasco, E. (2000).
Plasma leptin and insulin levels in Aymara natives from Chile. Ann. Hum. Biol.
27, 271–279. doi: 10.1080/030144600282163
Schwartz, M. W., and Porte, D. Jr. (2005). Diabetes, obesity, and the brain. Science
307, 375–379. doi: 10.1126/science.1104344
Shek, E. W., Brands, M. W., and Hall, J. E. (1998). Chronic leptin infusion
increases arterial pressure. Hypertension 31, 409–414. doi: 10.1161/01.HYP.31.
1.409
Simonds, S. E., Pryor, J. T., Ravussin, E., Greenway, F. L., Dileone, R.,
Allen, A. M., et al. (2014). Leptin mediates the increase in blood
pressure associated with obesity. Cell 159, 1404–1416. doi: 10.1016/j.cell.2014.
10.058
Stocker, S. D., and Gordon, K.W. (2015). Glutamate receptors in the hypothalamic
paraventricular nucleus contribute to insulin-induced sympathoexcitation. J.
Neurophysiol. 113, 1302–1309. doi: 10.1152/jn.00764.2014
Tovar, S., Nogueiras, R., Tung, L. Y., Castañeda, T. R., Vázquez, M. J., Morris, A.,
et al. (2005). Central administration of resistin promotes short-term satiety in
rats. Eur. J. Endocrinol. 153, R1–R5. doi: 10.1530/eje.1.01999
Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., et al.
(1993). Differential effects of hyperinsulinemia and carbohydrate metabolism
on sympathetic nerve activity and muscle blood flow in humans. J. Clin. Invest.
92, 147–154. doi: 10.1172/JCI116542
Ward, K. R., Bardgett, J. F., Wolfgang, L., and Stocker, S. D. (2011).
Sympathetic response to insulin is mediated by melanocortin 3/4 receptors
in the hypothalamic paraventricular nucleus. Hypertension 57, 435–441.
doi: 10.1161/HYPERTENSIONAHA.110.160671
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Habeeballah, Alsuhaymi, Stebbing, Jenkins and Badoer. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Physiology | www.frontiersin.org 9 January 2017 | Volume 7 | Article 672
